Abstract
Accumulated end-products were identified to participate in the late development of glucose intolerance and insulin resistance (IR) in patients with chronic renal insufficiency. The possible pathophysiological role of accumulated 5-hydroxyindoleacetic acid (5HIAA) in the genesis of IR was investigated employing anin vitro animal model. 5HIAA inhibited the basal glucose uptake in isolated rat soleus muscle with intact membrane with A50=1.25 μmol/l, and Emax=88.6%. 5HIAA significantly inhibited the insulin, and tolbutamide stimulated glucose uptake. In Ca and Mg depletion 5HIAA showed a partially additive inhibitory effect, while nonadditive inhibitory activity was observed in the case of K+ excess. It is concluded that 5HIAA is a metabolically active end-product interfering with glucose uptake in muscle at an insulin postreceptor level, and its effect is related to Ca modulation in the insulin regulatory cascade.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Fuster, V., Badimon, L., Badimon, J. J., Chesebro, J. H.: Pathogenesis of coronary artery disease and the acute coronary syndrome.N. Engl. J. Med., 326, 242 (1992).
Diamond, J. R.: Analogous pathobiologic mechanisms in glomerulosclerosis and atherosclerosis.Kidney Int. (Suppl. 31), S29 (1991).
Dzúrik, R., Spustová, V., Janeková, K.: The prevalence of insulin resistance in kidney disease patients before the development of renal failure.Nephron, 69, 281 (1955).
Dzúrik, R., Hupková, V., Černáček, P., Valovičová, E., Niederland, T. R.: The isolation of an inhibitor of glucose utilization from the serum of uraemic patients.Clin. Chim. Acta, 46, 77 (1973).
Spustová, V., Černay, P.: Inhibition of glucose utilization in uremia by hippurate: Liquid chromatographic isolation and mass spectrometric and nuclear magnetic resonance spectroscopic identification.J. Chromatogr., 490, 186 (1989).
Lajdová, I., Spustová, V., Mikula, J., Černay, P., Dzúrik, R.: Isolation of an inhibitor of glucose utilization in renal insufficiency: Pseudouridine.J. Chromatogr., 528, 178 (1990).
DeFronzo R. A., Alveestrand, A., Smith, D., Hendler, R.: Insulin resistance in uremia.J. Clin. Invest., 67, 563 (1981).
Friedman, J. E., Dohm, G. L., Elton, C. W., Rovira, A., Chen, J. J., Leggett-Frazier, N., Atkinson, S. M. Jr., Thomas, F. T., Long, S. D., Caro, J. F.: Muscle insulin resistance in uremic humans: Glucose transport, glucose transporters, and insulin receptors.Am. J. Physiol., 261 (1Ptl), E87 (1991).
Spustová V., Dzúrik, R.: The mechanism of hippurate inhibition of glucose utilization in rat diaphragm.Biochem. Clin. Bohemoslov., 20, 21 (1991).
Dzúrik, R., Spustová, V., Lajdová, I.: Inhibition of glucose utilization in isolated rat soleus muscle by pseudouridine: Implications for renal failure.Nephron, 65, 108 (1993).
Šebeková, K., Opatrný, K., Dzúrik, R.: Plasma levels of 5-hydroxyindole-acetic acid in chronic renal insufficiency and their effect on platelet aggregation.Nephron, 2, 253 (1991).
Šebeková, K: Unpublished results.
Tallarida, R. J., Murray, R. B.: Manual of Pharmacological Calculations with Computer Programs. 2nd ed. Springer, New York 1987.
Fosset, M., De Wielle, J. R., Green, R. D., Schmid-Antomarchi, H., Lazdunski, J.: Antidiabetic sulfonylurease control action potential properties in heart cells via high affinity receptors that are linked to ATP-dependent K+-channels.J. Biol. Chem., 263, 7933 (1988).
Šebeková, K., Štefíková, K., Mosárová, M., Jakubovská, Z., Polakovičová, D. Spustová, V., Dzúrik, R.: Insulin resistance and free to bound magnesium shifts in essential hypertension. In: Golf, S., Dralle, D., Vecchiet, L. (eds.), Magnesium 1993. John Libbey Co. Ltd., London 1994, p. 343.
Dzúrik, R., Spustová, V.: Accumulated end products participate in glucose intolerance and insulin resistance in uremia.Nephron, 65, 481 (1993).
Yki-Jarvinen H.: Pathogenesis of non-insulin-dependent diabetes mellitus.Lancet, 343, 91 (1994).
Williams, B.: Insulin resistnace: The shape of things to come.Lancet, 344, 521 (1994)
O'Rahilly, S., Hattersley, A., Vaag, A., Gray, H.: Insulin resistance as the major cause of impaired glucose tolerance: A self-fulfilling prophesy?.Lancet, 344, 585 (1994).
Kelley, D., Mitrakou, A., March, H.: Skeletal muscle glycolysis, oxidation, and storage of an oral glucose load.J. Clin. Invest., 81, 1563 (1994).
Ferrannini, E., Bjorkman, O., Reichard, G.: The disposal of an oral glucose load in healthy subjects: A quantitative study.Diabetes, 34, 580 (1985).
Fukufumi, H., Kayano, T., Buse, J. B.: Cloning and characterization of the major insulin-responsive glucose transporter expressed in human skeletal muscle and other insulin-responsive tissues.J. Biol. chem., 264, 7776 (1989).
Fink, R. I., Wallace, P., Brechtel, P., Olefsky, J. M.: Evidence that glucose transport is rate-limiting for in vivo glucose uptake.Metabolism, 41, 897 (1992).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Šebeková, K., Spustová, V. & Dzúrik, R. Inhibition of glucose uptake by 5-hydroxyindoleacetic acid in the isolated rat soleus muscle. International Urology and Nephrology 28, 123–131 (1996). https://doi.org/10.1007/BF02550149
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02550149